COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03252535
Brief Title: Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease (ADORE-DH)

First Submitted : August 15, 2017
First Submitted that Met QC Criteria : August 16, 2017
First Posted : August 17, 2017

Last Update Submitted that Met QC Criteria : December 11, 2019
Last Update Posted : December 13, 2019